Tivicay and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tivicay (dolutegravir sodium) and Ezetimibe (ezetimibe). Common drug interactions include anhedonia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Tivicay and Ezetimibe. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Tivicay?

Tivicay has active ingredients of dolutegravir sodium. It is often used in hiv infection. eHealthMe is studying from 9,674 Tivicay users. Check the latest studies of Tivicay.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.



On Jul, 16, 2026

43 people who take Tivicay and Ezetimibe together, and have interactions are studied.

Tivicay and Ezetimibe drug interactions.

What are the common drug interactions of Tivicay and Ezetimibe, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Proteinuria (presence of protein in the urine)
  7. Anaemia (lack of blood)
  8. Asthenia (weakness)
  9. Osteoporosis (bones weak and more likely to break)
  10. Abdominal distension

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Back pain
  4. Fatigue (feeling of tiredness)
  5. Gait disturbance
  6. Insomnia (sleeplessness)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Osteoporosis (bones weak and more likely to break)
  9. Decreased activity
  10. Diarrhoea

What are the common drug interactions of Tivicay and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Back pain
  5. Blood creatinine increased
  6. Depression
  7. Emotional distress
  8. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  9. Insomnia (sleeplessness)
  10. Nocturia (the need to get up in the night to urinate)

40-49:

  1. Insomnia (sleeplessness)
  2. Nocturia (the need to get up in the night to urinate)
  3. Pain
  4. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  5. Renal failure (kidney dysfunction)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Back pain
  9. Blood creatinine increased
  10. Chronic kidney disease

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Anaemia (lack of blood)
  7. Fatigue (feeling of tiredness)
  8. Depression
  9. Proteinuria (presence of protein in the urine)
  10. Back pain

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Pancreatitis relapsing
  4. Renal failure (kidney dysfunction)
  5. Abdominal distension
  6. Abdominal pain
  7. Blood creatinine increased
  8. Bone loss
  9. Constipation
  10. Drug intolerance (drug sensitivity)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 4 people, 9.30%
  2. Pain: 4 people, 9.30%
  3. High Blood Pressure: 4 people, 9.30%
  4. Bacterial Infection: 4 people, 9.30%
  5. Rickets (softening of bones): 3 people, 6.98%
  6. Rashes (redness): 3 people, 6.98%
  7. Infection: 3 people, 6.98%
  8. Hypersensitivity: 3 people, 6.98%
  9. Fungal Infection: 3 people, 6.98%
  10. Dyspnea (difficult or laboured breathing): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Tivicay and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tivicay and Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tivicay:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tivicay and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir sodium and ezetimibe (the active ingredients of Tivicay and Ezetimibe, respectively), and Tivicay and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: